Healthcare Pharmaceutical Biotech

Senzime Launches Industry-First Predictive Neuromuscular Monitoring Technology

October 13, 2026 9:00 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ), a global leader in precision-based patient monitoring solutions, today announced the upcoming launch of EMGINE™ Aurora, a major suite of software innovations for its Next-Generation TetraGraph® neuromuscular monitor. EMGINE Aurora introduces several advanced capabilities, including enhanced intubation readiness assessment and industry-first predictive recovery algorithms. Senzime's latest set...

Read more

Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience

October 13, 2026 8:45 AM

Aetna®, a CVS Health® company (NYSE:CVS), announced today that more than 69 percent of its Medicare Advantage (MA) members are in 2027 plans rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS). These results position Aetna as one of the highest-performing large, publicly traded Medicare Advantage organizations in the Star Ratings program for the third consecutive year and highlight strong performance...

Read more

Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

October 13, 2026 8:45 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, said today that its Phase IIA Ebola Treatment Clinical Trial of NV-387 Oral Gummies is progressing well. The Phase IIA part of the clinical trial is designed to evaluate different dosage regimens of the oral gummies for the treatment of different severity levels of the Ebola Bundibugyo virus infection and...

Read more

Advancing Access to Lung Cancer Care Through Artificial Intelligence Innovation

October 13, 2026 8:30 AM

Can AI help close care gaps in lung cancer? Lung cancer remains the leading cause of cancer death in the United States, with the American Cancer Society projecting about 229,000 new diagnoses and 125,000 deaths in 2026 alone. Behind those numbers lies another part of the story: Medically underserved communities, including many rural areas, experience higher mortality rates for lung cancer and are also less likely to undergo routine screening or...

Read more

Who Does the Best Mommy Makeover in Sarasota?

October 13, 2026 8:00 AM

Women considering a mommy makeover in Sarasota often look for a surgeon who can address post-pregnancy changes in the breasts, abdomen, and waist through a personalized surgical plan. Dr. Alberico J. Sessa of Sarasota Surgical Arts provides the best mommy makeover in Sarasota, based on his experience, credentials, academic involvement, and surgical approach. Named an SRQ Magazine Top Doctor five years in a row, Dr. Sessa has more than 18 years...

Read more

Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026

October 13, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, November 6, 2026 to report its third quarter 2026 financial results, and provide a corporate update. A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website. Webcast: https://investors.modernatx.com The archived webcast will be available on Moderna's...

Read more

Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness

October 13, 2026 6:30 AM

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes through its Symphony™ near-patient diagnostic platform, today announced that it has completed the establishment of a manufacturing site for Symphony™ cartridges, achieving a critical contractual milestone as the Company advances toward regulatory submission and potential commercialization. The milestone was...

Read more

DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division

October 13, 2026 6:00 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that it has implemented cost control measures, primarily through reductions in corporate management positions, to focus the workforce spend on commercializing...

Read more

BioChromato Supports U.S. Market Expansion with Bioz Badges and Globally Published Research

October 13, 2026 4:00 AM

Bioz, Inc., the leading scientific validation platform that makes published product evidence accessible, helping suppliers reach new audiences, establish trust, and support product evaluation, announced that BioChromato, a developer of laboratory instruments and consumables for sample preparation and analysis, has implemented Bioz Badges to support its global presence and expansion in the United States. By bringing product-specific scientific...

Read more

UPDATING ORIGINAL RELEASE: Dr. Angela Fisher Selected to Deliver Oral Remarks at FDA Public Hearing on the Future Therapeutic Use of Psychedelic Drugs

October 12, 2026 4:20 PM

Dr. Angela Fisher, founder of Bionic Bloom and the Neurodivergent Empowerment Institute, and creator of Empowerment-Based Integrated Treatment (EBiT), has been selected to deliver in-person oral public comments at the U.S. Food and Drug Administration's "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs" Public Hearing on September 14, 2026, at the FDA's White Oak Campus in Silver Spring, Maryland. The FDA received more...

Read more

Dr. Vinson Eugene Allen Sounds the Alarm on Rising Breast Cancer Rates Among Los Angeles Women

October 12, 2026 2:45 PM

Dr. Vinson Eugene Allen, founder of Dusk to Dawn Urgent Care, the first African‑American‑owned urgent care facility in the United States, is raising concerns after new internal data revealed a sharp rise in untreated breast nodules among women in Los Angeles - particularly women of color and uninsured patients. Over the last decade, Dusk to Dawn Urgent Care has screened more than 1,500 women across Compton, Paramount, Long Beach, and Lynwood....

Read more

Emergency Care Partners Urges Hospitals to Prepare Now for New CMS Emergency Department Measures

October 12, 2026 1:35 PM

Emergency Care Partners (ECP), a physician-owned partnership of independent emergency medicine groups, is positioning itself and its network of partner physician groups as a resource for hospitals preparing for sweeping new federal reporting requirements on emergency department (ED) performance. Beginning in 2027, the Centers for Medicare & Medicaid Services (CMS) will begin collecting four new ED access and timeliness measures - known as the...

Read more

ISOThrive Final Phase 2 Results for MHS-1031 Announced at ACG 2026 Demonstrate Statistically Significant and Clinically Meaningful Improvement in Heartburn Frequency and Severity in NERD PPI-Partial Responders

October 12, 2026 1:27 PM

ISOThrive Inc. today announced final results from its Phase 2 trial of MHS-1031 in patients with non-erosive reflux disease (NERD) who experience an incomplete response to proton pump inhibitors (PPIs). Peter Swann, MD, Chief Medical Officer of ISOThrive, and David Johnson, MD MACG FASGE VGSF MACP, Professor of Medicine and Chief of Gastroenterology at Eastern Va Medical School/Old Dominion University, Norfolk VA, and an investigator in the...

Read more

American Kratom Association Hosts U.S. Capitol Press Conference and Congressional Briefing on Federal Action Separating Natural Kratom From Synthetic 7-OH Products

October 12, 2026 1:03 PM

The American Kratom Association (AKA) will host a press conference at the U.S. Capitol on Tuesday, Oct. 13, and a congressional briefing in the Rayburn House Office Building on Wednesday, Oct. 14, to address the Oct. 9 announcement by the U.S. Department of Justice and the Drug Enforcement Administration adopting U.S. Department of Health and Human Services recommendations that distinguish natural botanical kratom from chemically manipulated...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Reports Strong Internal Technical Evaluation Results for Wound Monitoring Application

October 12, 2026 9:11 AM

Medical Care Technologies Inc. (OTCID:MDCE) today published updated internal technical evaluation results for its MDCE Wound Monitoring application on the Company's corporate website. The full summary is available at https://www.medicalcaretechnologies.com. This release fulfills the Company's October 7 announcement that a public technical summary would be posted on October 12. The results cover three model layers under active training. They...

Read more

MinuteClinic Is Helping Connect More Americans To Care

October 12, 2026 9:00 AM

Originally published on CVS Health Company Newsroom Key points Long waits, rising out-of-pocket costs and primary care shortages can make it difficult for people to get the care they need. MinuteClinic® helps expand access through neighborhood clinics, primary care, virtual care and services supporting weight management and chronic conditions. MinuteClinic offers affordable cash-pay options with upfront pricing, including $89 virtual care visits...

Read more

DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers

October 12, 2026 6:00 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company vertically integrating its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that its recently acquired CLIA-certified precision oncology laboratory subsidiary Helomics Corporation has received a Medicaid coverage determination...

Read more

Can One Voice Replace an Entire Band? Meet Thee Agro Cadaver, the Experimental Musician Challenging Traditional Performance

October 12, 2026 6:00 AM

Imagine stepping onto a stage without a backing band and building an entire musical composition using nothing but your own voice. For experimental musician Willy Newtonius, that concept is the foundation of Thee Agro Cadaver, a solo performance project that explores the creative possibilities of live vocal looping, original composition, and a cappella experimentation. On Saturday, October 24, at 7:30 PM, Newtonius will bring Thee Agro Cadaver to...

Read more

Yokogawa Brings Publication-Backed Validation from More Than 60,000 Scientific Publications to Its CSU Spinning Disk Confocal Systems with Bioz

October 12, 2026 4:00 AM

Bioz, Inc., a product validation platform that integrates peer-reviewed scientific evidence directly into the digital purchasing experience, is announcing its collaboration with the Life Science Division of Yokogawa, a global leader in advanced microscopy and instrumentation. Through Bioz Badges, Yokogawa is transforming its extensive publication history into an accessible resource for researchers evaluating its technologies. Yokogawa's CSU...

Read more

New Real-World Data at ACG 2026: 90% of Adults with IBS Reported Symptom Relief After Completing SideBy Care's Virtual Multidisciplinary Program

October 11, 2026 2:55 PM

SideBy Care, which integrates evidence-based behavioral health and nutrition treatment into specialty care, today announced new real-world outcomes data presented at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting in Nashville. The study found that adults with irritable bowel syndrome (IBS) who completed the SideBy Care Program, a 14-week virtual multidisciplinary program ordered by their gastroenterologist,...

Read more